Navigation Links
NIS in Medical News

Pointer Announces Negotiations by Shagrir for Formation of a Joint Venture With a Third Party for the Provision of Services to Insurance Companies in the Field of Dental Care

...h has been active for the past eighteen years in providing services to insurance companies in the field of dental care, for an amount of approximately nis 20 million, subject to adjustments. The agreement between Shagrir and Multimatrix and between the joint venture and IRM Group would be subject, among ...

Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results

... 18,921 MINORITY INTERESTS 800 1,250 SHAREHOLDERS' EQUITY: Share capital Common shares of nis 0.01 par value Authorized: 100,000,000 shares at December 31, 2007 and December 31, 2008; Issued and outstanding: 16,423,740 share...

Shamir Optical Industry Ltd. Reports Third Quarter 2008 Results

... 23,368 MINORITY INTERESTS 800 1,322 SHAREHOLDERS' EQUITY: Share capital Common shares of nis 0.01 par value Authorized: 100,000,000 shares at December 31, 2007 and September 30, 2008; Issued and outstanding: 16,423,740 ...

Elbit Imaging Ltd. Announces Second Quarter Results for 2008

... Profit for the second quarter of 2008 amounted to nis 56.0 million (approximately US$ 16.7 million) of which profit of nis 15.8 million (approximately US$ 4.7 million) is at...ributable to the equity holders of the Company and nis 40.3 million (approximately US$ 12.0 million) is a...

ACS Motion Control Ltd. Reports Second Quarter Results

... 191 198 Total liabilities 2,968 1,981 2,871 Shareholders' equity Share capital - Ordinary Shares of nis 0.01 par value Authorized - 8,000,000 shares Issued - June 30, 2008, June 30, 2007 and December 31, 2007- 3,280,752 Outstanding - June 30, 2008, ...

New therapy shows promise for fighting treatment-resistant cancer cells

...y Chung, a professor of nuclear medicine at Seoul National University College of Medicine, Seoul, South Korea, and lead researcher of the study, Human nis Gene Radiotherapy Targeting HIF-1 Activated Cancer Cells. "Our research shows that this system successfully targets these hard-to-treat cells in vitro...

Elbit Imaging Ltd. Announces First Quarter Results for 2008

.... Loss for the first quarter of 2008 amounted to nis 3.5 million (approximately US$ 1.0 million) of which loss of nis 27.3 million (approximately US$ 7.7 million) is at...the equity holders of the Company, while profit of nis 23.8 million (approximately US$ 6.7 million) is at...

Shamir Optical Industry Ltd. Reports First Quarter 2008 Results

... 924 ------------------ ------------------ SHAREHOLDERS' EQUITY: Share capital Common shares of nis 0.01 par value Authorized: 100,000,000 shares at December 31, 2007 and March 31, 2008; Issued and outstanding: 16,423,740 shares at...

Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2007 Results

... 800 ------------------ ------------------ SHAREHOLDERS' EQUITY: Share capital Common shares of nis 0.01 par value Authorized: 100,000,000 shares at December 31, 2006 and December 31, 2007; Issued and outstanding: 16,256,514 and 16,423...

012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007

... For 2007: Record Revenues of nis 1.1 Billion With a 14% Rise in Core ...31, 2007. 2007 Highlights - Record revenues of nis 1.1 billion ($287.1 million) in line with merger p...re due to IPO: Cash and equivalents increased from nis 38.0 million at the end of 2006 to...

More>>

NIS in Biological Technology

Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist

JERUSALEM, Israel, August 4 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), a developer of oral delivery systems, today reported that its wholly owned Israeli subsidiary, Oramed Ltd., was awarded a government grant amounting to a total net amo...

Corrected: XTL Biopharmaceuticals to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter

...ted and re-divided so that each five (5) shares of nis 0.02 nominal value shall be consolidated into one (1) share of nis 0.1 nominal value; 8. that the registered ...,000,000 divided into 100,000,000 ordinary shares, nis 0.1 nominal value, to NIS 70,000,000 divided into ...

XTL Biopharmaceuticals to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter

...ted and re-divided so that each five (5) shares of nis 0.02 nominal value shall be consolidated into one (1) share of nis 0.1 nominal value; 9. that the registered ...,000,000 divided into 100,000,000 ordinary shares, nis 0.1 nominal value, to NIS 70,000,000 divided into ...

Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone

...9. The grant will provide cash reimbursements of 40% of expenses paid for hGH-CTP product development during this period, up to a limit of 10 million nis (about $2.6 million). Human growth hormone is a natural protein produced by the pituitary gland in the brain. It fuels growth of the body's bone ...

D-Pharm Secures Funding From Israel's Chief Scientist's Office

...ice from Israel's Chief Scientist's Office (CSO) of its commitment to match expenditures on four of D-Pharm's R&D programs with a total grant of up to nis 11 million (over $3 million). Alex Kozak, PhD, CEO and President of D-Pharm, said "We are grateful to the CSO for this vote of confidence and its fi...

Clal Industries Commences Additional Offer Period for Fundtech Tender Offer

...ng day before this announcement, the closing sale price of the Fundtech shares was $12.41 on Nasdaq and NIS 45.16 ($12.72 based on an exchange rate of nis 3.5 per United States dollar as of April 2, 2008) on the Tel Aviv Stock Exchange (TASE). The complete terms and conditions of the tender offer, incl...

Elbit Imaging Ltd. Announces Results For Fiscal Year 2007

...mpany as of the Transition Date has increased from nis 1,054 million reported in accordance with Israeli GAAP to nis 1,098 million reported in accordance with IFRS. In...to the equity holder of the Company decreased from nis 561.1 million reported in accordance with Israeli ...

Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend

...representative rate of exchange), or approximately US$ 0.243 (approximately nis 0.917 based on the January 11, 2008 representative rate of exchange) per or...the name of the nominee company of Bank Hapoalim Ltd.), who will be paid in nis according to the representative rate of exchange published by the Bank of I...

Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results

...23 1,319 ------------- ------------- SHAREHOLDERS' EQUITY: Share capital Common shares of nis 0.01 par value Authorized: 100,000,000 shares at December 31, 2006 and September 30, 2007; Issued and outstanding: 16,256,514 and 16,423,740 ...

Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007

...tCall/ -- - Third quarter Consolidated Net Income nis 178 Million, Compared to NIS 24 Million Last Year;...age of USD/bbl 3.75 - Consolidated EBITDA totaled nis 326, compared to nis 144 million in third quarter 2006 - Consolidated ...

More>>

Other Tags
(Date:7/10/2014)... 2014 Fatigue, lack of safety ... number of accidents in the workplace, according to ... articles highlight safety issues that contribute to the ... occur on the job annually, according to the ... explore "preventable workplace accidents." , Safety Issue: "Extended ...
(Date:7/10/2014)... July 10, 2014 Thousands of ... in Copenhagen this July 13-17 to reveal the ... world closer to breakthroughs in dementia science. The ... largest conference of its kind. , As part ... as a catalyst for generating new knowledge about ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Register to ... DataSite recently streamed the live webinar ‘Capitalizing on the ... from a group of several M&A experts in the ... the broader energy transaction marketplace. These experts shared their ... the deal market in this sector has been revitalized. ...
(Date:7/10/2014)... NY (PRWEB) July 10, 2014 CBPartners, ... sciences industry, has launched a new website. The ... well as increased access to the firm’s thought pieces, ... provides an ideal platform to showcase our insights, capabilities, ... issues,” says CBPartners’ Chief Executive Officer, Cyrus Chowdhury. ...
(Date:7/10/2014)... 10, 2014 Best Drug ... that having family close by during a stay ... whether or not the process is successful, has ... website at http://www.bestdrugrehabilitation.com/success-stories/ . , The new ... testimonials from several Best Drug Rehabilitation graduates who ...
Breaking Medicine News(10 mins):Health News:Safety Reboot Magazine Focuses on: Why Extended Hours is Dangerous in the Workplace; Why Custodial Work Can be Dangerous; and Improving Safety for Roofers 2Health News:Safety Reboot Magazine Focuses on: Why Extended Hours is Dangerous in the Workplace; Why Custodial Work Can be Dangerous; and Improving Safety for Roofers 3Health News:Register to Download Merrill DataSite's Report: Capitalizing on the Shifting Sands of the Energy Market 2Health News:CBPartners Announces New Website 2Health News:Best Drug Rehabilitation Launches New Success Stories Section of Website 2
(Date:7/11/2014)... the brains of all vertebrates, information is transmitted ... or chemical signal to be passed from one ... the most abundant type of synapse, can be ... for learning, memory, perception and cognition, and the ... brain function. For instance, every time we ...
(Date:7/10/2014)... YORK , June 27, 2014  Pomerantz ... Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE-MKT: PVCT) ... filed in United States District Court, Middle District ... is on behalf of a class consisting of ... acquired Provectus securities between December 17, 2013 and ...
(Date:7/10/2014)... , July 2, 2014  Unisys Corporation,s (NYSE: ... Unisys Nederland N.V., today announced that it has been selected ... and manage a new Basic Provision Biometrics solution for penitentiaries ... Unisys won the contract with a solution based on its ... The term of the contract is up to seven years, ...
Breaking Biology News(10 mins):Blame it on the astrocytes 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3
Other Contents